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deletion of recipient dendritic cells surprisingly enhanced the ex-
pansion of donor alloantigen-specific T cells and accelerated
GVHD mortality due to a failure of activation-induced donor
T cell death. Consistent with this, the use of bone marrow-chi-
meric recipients demonstrated that professional, hematopoietic-
derived recipient APC in isolation were limited in their capacity
to induce GVHD. In contrast, non-hematopoietic recipient APC
in isolation induced universal GVHD mortality with high levels
of alloreactive donor T cell expansion and inflammatory cytokine
generation. Confocal imaging demonstrated that MHC class II is
highly expressed in recipient non-hematopoietic tissue within the
dermis and intestinal villi. Donor T cell activation (CD69) and
memory differentiation (CD62Llo/CD44hi) occurred in irradiated
recipients in an antigen-independent fashion and resulted in the
acquisition of a memory cell phenotype and Th1 differentiation
in lymph nodes. Within 3 days after BMT, these donor T cells
began entering the GI tract and interacted with MHC class II+
non-hematopoietic cells leading to lethal acute GVHD.
Conclusion: These data challenge current paradigms, demon-
strating that lethal acute GVHD can be induced by alloantigen
presented solely within MHC class II by non-hematopoietic re-
cipient APC.430
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Oral chronic graft-versus-host disease (cGVHD) is a serious com-
plication of allogeneic stem cell transplantation, and may be the pri-
mary site of disease activity. Scales and instruments recently
introduced to measure severity and response to therapy have not
been prospectively validated. The objective of this study was to de-
scribe the characteristics of oral cGVHD and determine the mea-
sures most sensitive to change.
Methods:Patients enrolled in the cGVHD Consortium with oral
involvement were included. Clinicians scored oral cGVHD ac-
cording to the 2005 NIH criteria for severity scoring (0-3) and
response (erythema, lichenoid changes, ulcers, mucoceles), and
patients completed measures. Other evaluated measures included
the esophageal response measure, Hopkins mouth score, and
weight. Clinicians and patients also rated change on an 8-point
scale, categorized as improved (1-3), stable (4-6), or worsened
(7-8).
Results: Of 458 participants with cGVHD, 72% (n 5 331) had oral
cGVHD involvement at enrollment and were followed for a median
of 13.6 months (2.0-38.5). Lichenoid change was the most common
objective finding (n5 293; 89%), and 25%of patients had only lichen-
oid involvement. Oral cGVHDwas not associated with global quality
of life as measured by the FACT-BMT or SF-36. At visits where
change could be assessed (n 5 501, 52% of follow-up visits), 51% of
clinicians and 56%patients reported improvement, withworsening re-
ported in 4-5% for both groups; agreement between clinician and pa-
tient perceived change was fair (weighted kappa5 0.41), but only 1%
of visits had highly discordant changes (improve vs. worse). Multivari-
able regression modeling suggested that the serial measurement
changes most predictive of perceived change by clinicians and patients
were the erythema and lichenoid scores, NIH severity score, clinician
assessed pain score and patient assessed Lee oral symptom score. Serial
change in erythema and lichenoid features showed synergy, with more
combined impact than each feature alone. Perceived changes in oral
cGVHDwere not associated with change in ulcers, mucoceles, esoph-
ageal scores or patient weight.
Conclusions: Oral involvement in cGVHD is common and associ-
ated with a wide range of signs and symptoms that generally improve
with time. Measurement of oral erythema and lichenoid changes,
pain and patient symptoms using 6 questionsmay adequately capture
the activity of oral cGVHD in clinical trials.431
REGULATION OF INTESTINAL INFLAMMATION BY INTESTINAL MICRO-
BIOTA FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION
Jenq, R.R.1, Ubeda, C.1, Blazar, B.2, Pamer, E.1, van den Brink, M.1
1Memorial Sloan-Kettering Cancer Center, New York, NY; 2University
of Minnesota
Following allogeneic bone marrow transplantation (allo BMT),
patients are at high risk for developing intestinal inflammation sec-
ondary to graft-versus-host disease (GVHD). While the impact of
the microbiota on GVHD is known to be significant, no consensus
exists between BMT centers regarding the optimal approach to tar-
get the flora.
We first examined in mouse models the effects of GVHD on gut
flora. While BMT alone produced surprisingly few changes in the
flora of mice, with GVHD we observed loss of overall diversity,
and in particular expansion of Lactobacillales and loss of Clostri-
diales. We studied the effects of eliminating Lactobacillales from
the flora of mice prior to BMT using antibiotics and observed aggra-
vation of GVHD, while re-introducing the predominant species of
Lactobacillus mediated significant protection resulting in improved
survival. These results frommurinemodels suggest thatGVHDpro-
duces unique changes in the flora, and that changes induced by anti-
biotics can aggravate GVHD.
We then characterized gut flora of eight patients undergoing allo
BMT during onset of intestinal inflammation due to GVHD, com-
pared to ten patients without GVHD. We again found patterns of
loss of diversity, expansion of Lactobacillales, and loss of Clostri-
diales, mirroring our findings in mice. We also identified increased
microbial chaos early following allo BMT as a potential risk factor
for subsequent GVHD. Together, these data increase our apprecia-
tion for reciprocal regulation of inflammation and flora in the intes-
tine, and suggest that flora manipulation may improve outcomes for
allo BMT recipients.Table. Summary of GVHD-induced changes in themicrobiota
Mice HumansNo GVHD GVHD No GVHD GVHDFlora diversity no change decreased no change decreased
Lactobacillales no change increased no change increased
Clostridiales no change decreased no change decreased432
IDENTIFICATION OF A NEW HY MINOR IN THE UTY GENE USING RE-
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Introduction: Minor histocompatibility antigens located on the Y-
chromosome (HYminors) are known to play a pivotal role in alloge-
neic hematopoietic cell transplantation (HCT) with female donor
and male recipient. Only a few HYminors are known.We identified
a new HYminor using reverse immunology where candidate minors
first were predicted using bioinformatics and afterwards confirmed
with standard immune laboratory techniques.
Methods: Patient/donor pairs with female donors and male patients
were high resolution HLA typed. Candidate HY minor epitopes lo-
cated in genes only expressed on the Y chromosome were found us-
ing the HLA-pan restrictor (http://www.cbs.dtu.dk/services/
HLArestrictor). Post nonmyeloablative conditioning HCT PBMCs
from the patients were thawed, stimulated with these peptides and
tested for cytokine produktion (TNF-a and IFN-g) after restimula-
tion using flow cytometri. Approximately 140 peptides were synthe-
sized per patient/donor pair and the test for cytokine production was
carried out using a matrix system.When positive cytokine responses
were found, the optimal peptide and the HLA-restriction were de-
termined by affinity assays and tetramerstaining. Cytotoxity was
demonstrated by staining for CD107a.
Results: A strong cytokine response on an 11-mere peptide located
in the UTY gene was found in a patient transplanted for follicular
S364 Poster Session IIlymphoma.Within the 11-mere, the peptide with the highest affinity
to an MCH allele was a 9-mere and tetrameres with the MCH allele
A2402 and the 9-mere positively stained expanded T-cells. The tet-
ramere positive T-cells were found to be CD107a-positive after
stimulation with dendritic cells pulsed with the peptide. T-cells spe-
cific for that HY minor were found after expansion in two of four
A2402 positive patient/donor pairs with female donor and male pa-
tient.
Conclusion: A new HY minor has been identified using a high-
throughput methodology suitable for identifying more HY minors
and possibly also autosomally expressed minor histocompatibility
antigens.433
IS LIVER BIOPSY NECESSARY IN THE MANAGEMENT OF ALLOGENEIC
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Background: Liver function abnormalities are common after hema-
topoietic stem cell transplantation (HSCT) and liver biopsy is often
used to direct treatment. We reviewed 117 consecutive liver biopsies
during the last 8 years at our institution.
Materials and Methods: From 2003 to 2010, 117 liver biopsies were
performed on patients who had undergoneHSCT for hematological
malignancies and presented with liver dysfunction. All slides were
evaluated for features of GVHD by cholestasis, fibrosis, lobular in-
flammation, iron deposition and were graded from 0 to 3 (0 5
none, 1 5 mild, 2 5 moderate and 3 5 severe).
Results: The median age of the patients was 49 (range 14-66). Fifty
seven (49%) patients underwent related donor (RD) and 60 (51%)
unrelated donor (URD) transplantations. Preparative regimens
were applied based on their disease; GVHD prophylaxis was tacroli-
mus and mycophenolic acid in 105 (88%) patients; tacrolimus, siro-
limus and thymoglobulin in 6 (5%), and other regiments in 6 (5%).
Fifty nine patients were alive with a median follow up for the surviv-
ing patients of 4.2 years (range 0.9-9.3 years). Kaplan-Meier estimate
of overall survival at 6 years was 43% +/- 5%. Liver biopsies were
preformed at a median of 173 days post-transplant (range 22-1366
days). At the time of the liver biopsy, the median AST was 168 IU/
L (range 18-1425 IU/L), ALT 250 IU/L (range 38-1495 IU/L), total
bilirubin 1.1 mg/dL (range 0.1-26.8 mg/dL) and alkaline phospha-
tase 278 IU/L (range 69-1547 IU/L). On biopsy there were 107
(91%) patients with histological features of GVHD: mild 29
(27%), moderate 56 (52%) or severe 22 (21%). Iron deposition stud-
ies showed 5 (4%) patients without iron deposition, 23 (20%) pa-
tients grade 1, 38 (32%) patients grade 2, and 51 (44%) patients
grade 3. In multivariate analysis of relevant prognostic factors in-
cluding age, donor, total bilirubin, ALT and histological grade of
cholestasis, only total bilirubin of\5 1.5 IU/L predicted favorable
survival (hazard ratio 5 0.34; 95% CI 0.19 - 0.63, p 5 0.001).
Conclusion: Liver biopsy confirmed the presence of GVHD in most
patients. The histological features of GVHDand iron deposition did
not adversely influence the survival. The most significant predictor
of survival was the presence of cholestasis on biopsy and the elevation
of total bilirubin of.1.5 mg/dL. Our data indicated limited value of
liver biopsy in management of patients with liver dysfunction after
allogeneic stem cell transplantation.434
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Objectives: Donor T lymphocytes play a critical role in alloim-
mune reactivities after allogeneic hematopoietic stem cell trans-
plantation (allo-HSCT). CD28, inducible co-stimulator (ICOS)
and cytotoxic T-lymphocyte antigen 4 (CTLA-4) belong to the
same family of T-cell costimulatory molecules. After activation,
three effector pathways have been described for T-cell cytotoxic-
ity: granzyme B/perforin, Fas/Fas ligand (FasL) and secreted
molecules such as TNF-alpha. Near recently, several important
polymorphisms have been identified in those genes and reported
to be associated with the risk of autoimmune diseases, malignan-
cies and allograft rejection in solid organ transplantation patients.
However, such information is less available in allo-HSCT. In the
present study, we first investigated the influence of those genes
polymorphic features on the abilities of T-cell alloimmune re-
sponses in allo-HSCT setting.
Methods: We analyzed 10 single nucleotide polymorphisms
(SNPs) in the CD28, ICOS, CTLA-4, Granzyme B, Fas and
FasL genes in 138 pairs of recipients and their unrelated donors
(URDs) and 102 pairs of recipients and their HLA-identical sib-
ling donors.
Results: (1) We found two SNPs in donors influenced the risk of
aGVHD. The association was particularly strong in the URD trans-
plantation cohort. Unrelated donor with Granzyme B +55 mutated
genotype (AA) was an independent risk factor for grades II-IV
aGVHD (P5 0.024, RR5 1.811, 95%CI, 1.080-3.038). While un-
related donor with CTLA-4 CT60 mutated genotype (AA) was pro-
tective (P 5 0.025, RR 5 3.806, 95%CI, 1.187-12.204). (2)
However, donor with CTLA-4 CT60 AA genotype was a risk of
early CMV infection (P \ 0.0001, RR 5 0.383, 95%CI, 0.243-
0.605) and relapse after allo-HSCT in AML patients (P 5 0.047,
RR 5 2.792 95%CI, 1.013-7.696). Furthermore, AML patients
with Fas -670 homogeneous mutated allele (TT genotype) also
had a higher risk of relapse (P 5 0.003, RR 5 3.823 95%CI,
1.566-9.337). (3) The presence of those susceptible alleles in donor
and/ or recipient (patients receiving CTLA-4 CT60 AA donor, pa-
tients receiving GranzymeB +55 AA donor, AML patients with Fas
-670 TT genotype or with all) resulted in a reduced overall survival
compared with those with wild-type genotypes (54.9% vs 69.5%,
P 5 0.029).
Conclusions:The results of this study highlight the important effect
of genetic variations in T-cell activation and effector pathways from
the donors and recipients on the outcomes of allo-HSCT.435
SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE IS ASSOCIATED WITH
IMPAIRED THYMOPOIESIS AND PERIPHERAL LYMPHOCYTE EXPANSION
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Allogeneic hematopoietic stem cell transplantation (AHSCT) is
a curative therapy for hematologic malignancies. Chronic GVHD
(cGVHD) is a significant barrier to successful AHSCT. Although
T cells have been implicated in cGVHD pathobiology, the role
of the thymus in this process has yet to be clearly defined. We
characterized thymus and spleen T cell subsets in a murine
model of cGVHD (B10.D2/BALB/c) to investigate the role
of the thymus in this process. Once cGVHD was well-estab-
lished, 4-6 weeks post AHSCT, total thymocyte numbers in
mice with cGVHD were more than 20-fold depleted compared
to syngeneic controls. Furthermore, the double positive thymo-
cyte cell population (CD4+ CD8+) was most markedly reduced,
with a 90-fold reduction in numbers compared to syngeneic con-
trols. Despite evidence of thymic atrophy and diminished thymo-
poiesis, thymic CD4+ single positive cells were decreased less
proportionally (13-fold). Congenic AHSCT demonstrated that
this CD4+ population was comprised of donor peripherally de-
rived CD44hi memory T cells, representing an allogeneic infil-
trate. Further evidence of diminished thymic output was found
in the periphery. Live splenocytes were 3-fold depleted in
